{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:50:52Z","timestamp":1789753852788,"version":"4.0.1"},"reference-count":10,"publisher":"American Association for Cancer Research (AACR)","issue":"24","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>While the early use of antibiotics during chemotherapy may be lifesaving, antibiotic therapy is associated with worse outcomes in patients with ovarian cancer during platinum chemotherapy. The study by Chambers and colleagues in this issue of Cancer Research provides mechanistic insights into how disrupting the gut microbiome with broad-spectrum antibiotics negatively influences the survival of patients with ovarian cancer and highlights the impact of the gut microbiome on tumor progression and response to therapy. Treatment of ovarian cancer models with a broad-spectrum antibiotic cocktail (ABX, vancomycin, neomycin sulfate, metronidazole, ampicillin) changed the gut microbiome and increased tumor growth and development of cisplatin resistance. Stem cells, reported to drive resistance to chemotherapy and disease recurrence in ovarian cancer, were enriched as a surprising consequence of ABX-induced microbiome disruption. Immune-competent and immune-deficient mice revealed that ABX treatment enhanced the cisplatin-induced stemness and provided evidence for immune surveillance of ovarian cancer stem cells through the gut microbiome. Two gut-derived metabolites, indole-3-propionic acid and indoxyl sulfate, suppressed by ABX treatment and reestablished with cecal microbial transplantation colonization of ABX-treated mice, were identified as potential effectors connecting the gut microbiome to ovarian cancer growth. This clinically relevant study opens new therapeutic opportunities for patients\u2014one aimed at interventions to increase platinum sensitivity and another aimed at preventing the potential adverse effects of broad-spectrum antibiotic treatment. Both represent paradigm changes to standard care.<\/jats:p>\n                  <jats:p>See related article by Chambers et al., p. 4654<\/jats:p>","DOI":"10.1158\/0008-5472.can-22-3013","type":"journal-article","created":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T03:07:41Z","timestamp":1671160061000},"page":"4511-4512","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Unintended Consequences of Antibiotic Therapy on the Microbiome Delivers a Gut Punch in Ovarian Cancer"],"prefix":"10.1158","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0727-3971","authenticated-orcid":false,"given":"Shannon M.","family":"Hawkins","sequence":"first","affiliation":[{"name":"1Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, Indiana."},{"name":"2Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2192-1346","authenticated-orcid":false,"given":"Kenneth P.","family":"Nephew","sequence":"additional","affiliation":[{"name":"2Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana."},{"name":"3Medical Sciences Program, Indiana University School of Medicine, Bloomington, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2022,12,16]]},"reference":[{"key":"2025112417332208200_bib1","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ygyno.2014.12.007","article-title":"Surgical site infection after primary surgery for epithelial ovarian cancer: predictors and impact on survival","volume":"136","author":"Tran","year":"2015","journal-title":"Gynecol Oncol"},{"key":"2025112417332208200_bib2","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ygyno.2020.09.010","article-title":"Impact of antibiotic treatment during platinum chemotherapy on survival and recurrence in women with advanced epithelial ovarian cancer","volume":"159","author":"Chambers","year":"2020","journal-title":"Gynecol Oncol"},{"key":"2025112417332208200_bib3","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.3390\/cancers13163999","article-title":"Gut microbiota dynamics during chemotherapy in epithelial ovarian cancer patients are related to therapeutic outcome","volume":"13","author":"D'Amico","year":"2021","journal-title":"Cancers"},{"key":"2025112417332208200_bib4","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1158\/0008-5472.CAN-21-0106","article-title":"Altering the microbiome inhibits tumorigenesis in a mouse model of oviductal high-grade serous carcinoma","volume":"81","author":"Chen","year":"2021","journal-title":"Cancer Res"},{"key":"2025112417332208200_bib5","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1158\/0008-5472.CAN-22-0455","article-title":"Disruption of the gut microbiota confers cisplatin resistance in epithelial ovarian cancer","volume":"82","author":"Chambers","year":"2022","journal-title":"Cancer Res"},{"key":"2025112417332208200_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.stem.2018.11.017","article-title":"Targeting cancer stemness in the clinic: from hype to hope","volume":"24","author":"Saygin","year":"2019","journal-title":"Cell Stem Cell"},{"key":"2025112417332208200_bib7","doi-asserted-by":"crossref","first-page":"e122360","DOI":"10.1172\/jci.insight.122360","article-title":"IL-6 mediates platinum-induced enrichment of ovarian cancer stem cells","volume":"3","author":"Wang","year":"2018","journal-title":"JCI Insight"},{"key":"2025112417332208200_bib8","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12967-022-03447-y","article-title":"Platinum-induced mitochondrial OXPHOS contributes to cancer stem cell enrichment in ovarian cancer","volume":"20","author":"Sriramkumar","year":"2022","journal-title":"J Transl Med"},{"key":"2025112417332208200_bib9","doi-asserted-by":"crossref","first-page":"10976","DOI":"10.1016\/j.celrep.2021.109765","article-title":"Age and the aging process significantly alter the small bowel microbiome","volume":"36","author":"Leite","year":"2021","journal-title":"Cell Rep"},{"key":"2025112417332208200_bib10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ygyno.2021.01.015","article-title":"Impact of antibiotic treatment on immunotherapy response in women with recurrent gynecologic cancer","volume":"161","author":"Chambers","year":"2021","journal-title":"Gynecol Oncol"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/82\/24\/4511\/3230558\/4511.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/82\/24\/4511\/3230558\/4511.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T22:33:28Z","timestamp":1764023608000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/82\/24\/4511\/711514\/Unintended-Consequences-of-Antibiotic-Therapy-on"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,16]]},"references-count":10,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2022,12,16]]},"published-print":{"date-parts":[[2022,12,16]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-22-3013","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,16]]}}}